chr15-66703712-C-CCGGCGGG
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_005585.5(SMAD6):c.465_471dupCGGGCGG(p.Ser158fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,346,944 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
SMAD6
NM_005585.5 frameshift
NM_005585.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.333
Genes affected
SMAD6 (HGNC:6772): (SMAD family member 6) The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila 'mothers against decapentaplegic' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAdExome4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAD6 | NM_005585.5 | c.465_471dupCGGGCGG | p.Ser158fs | frameshift_variant | 1/4 | ENST00000288840.10 | NP_005576.3 | |
SMAD6 | NR_027654.2 | n.1488_1494dupCGGGCGG | non_coding_transcript_exon_variant | 1/5 | ||||
SMAD6 | XR_931827.3 | n.1488_1494dupCGGGCGG | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMAD6 | ENST00000288840.10 | c.465_471dupCGGGCGG | p.Ser158fs | frameshift_variant | 1/4 | 1 | NM_005585.5 | ENSP00000288840.5 | ||
SMAD6 | ENST00000557916.5 | n.465_471dupCGGGCGG | non_coding_transcript_exon_variant | 1/5 | 1 | ENSP00000452955.1 | ||||
SMAD6 | ENST00000612349.1 | n.647_653dupCGGGCGG | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000200 AC: 3AN: 150106Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
150106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000192 AC: 23AN: 1196838Hom.: 0 Cov.: 32 AF XY: 0.0000273 AC XY: 16AN XY: 585938
GnomAD4 exome
AF:
AC:
23
AN:
1196838
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
585938
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000200 AC: 3AN: 150106Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 73216
GnomAD4 genome
AF:
AC:
3
AN:
150106
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Radioulnar synostosis Pathogenic:1
Likely pathogenic, no assertion criteria provided | case-control | The Laboratory of Genetics and Metabolism, Hunan Children’s Hospital | May 14, 2019 | PVS1, PM2, PP4 - |
Aortic valve disease 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change creates a premature translational stop signal (p.Ser158Argfs*147) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. This variant is present in population databases (no rsID available, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with SMAD6-related conditions (PMID: 31138930, 32499606, 34953066). This variant is also known as c.454_455insCGGCGGG:p.P152fs. ClinVar contains an entry for this variant (Variation ID: 405520). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2022 | Identified in an individual with nonsyndromic radioulnar synostosis (Yang et al., 2019); Frameshift variant predicted to result in protein truncation, as the last 339 amino acids are replaced with 146 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 34953066, 31138930, 32499606) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at